Paragon Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-228
Closed -$202K 79
2024
Q3
$202K Hold
228
0.15% 83
2024
Q2
$206K Buy
+228
New +$182K 0.16% 82

Other funds holding LLY

Paragon Financial Partners's LLY Position: Q4 2024 in Review

Paragon Financial Partners sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 228 shares — an estimated $202K sold.

Paragon Financial Partners first reported a position in LLY in Q2 2024 and held it in 2 quarters. The position peaked at $206K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Paragon Financial Partners reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Paragon Financial Partners sold 228 Eli Lilly shares in Q4 2024, an estimated $202K.
  • Paragon Financial Partners first reported a position in Eli Lilly in Q2 2024 and held it in 2 quarters.
  • Paragon Financial Partners's Eli Lilly position peaked at $206K in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Paragon Financial Partners's 13F filing for Q4 2024, filed 17 Jan 2025.